PTN
Palatin Technologies Inc
AMEX: PTN · HEALTHCARE · BIOTECHNOLOGY
$20.21
-0.30% today
Updated 2026-04-30
Market cap
$37.58M
P/E ratio
—
P/S ratio
4.19x
EPS (TTM)
$-8.26
Dividend yield
—
52W range
$2 – $31
Volume
0.0M
Palatin Technologies Inc (PTN) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-107.40%
Operating margin
-6,316.00%
ROE
-378.70%
ROA
-70.30%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $19.75M | $-28.96M | 88.15% | -154.19% | -146.64% |
| 2007 | $14.41M | $-27.75M | 100.00% | -206.87% | -192.64% |
| 2008 | $11.48M | $-14.38M | 100.00% | -144.84% | -125.26% |
| 2009 | $11.35M | $-4.80M | 100.00% | -64.32% | -42.30% |
| 2010 | $14.18M | $-1.79M | 100.00% | -21.26% | -12.64% |
| 2011 | $1.48M | $-12.82M | 100.00% | -925.37% | -868.61% |
| 2012 | $73736.00 | $-17.25M | 100.00% | -25,476.54% | -23,398.58% |
| 2013 | $10361.00 | $-20.86M | -101,518.48% | -150,421.39% | -201,352.90% |
| 2014 | $0.00 | $-13.93M | — | — | — |
| 2015 | $12.95M | $-17.67M | -89.63% | -133.47% | -136.40% |
| 2016 | $0.00 | $-51.71M | — | — | — |
| 2017 | $44.72M | $-13.33M | 100.00% | -23.63% | -29.81% |
| 2018 | $67.13M | $24.70M | 51.49% | 38.62% | 36.80% |
| 2019 | $60.30M | $35.77M | 75.36% | 59.28% | 59.32% |
| 2020 | $117989.00 | $-22.38M | 100.00% | -20,007.61% | -18,969.53% |
| 2021 | $-188597.00 | $-33.57M | 178.39% | 17,701.29% | 17,799.23% |
| 2022 | $1.47M | $-35.81M | 85.19% | -2,491.63% | -2,438.49% |
| 2023 | $4.85M | $-27.54M | 91.38% | -668.75% | -567.44% |
| 2024 | $4.49M | $-29.74M | 97.83% | -501.02% | -662.26% |
| 2025 | $0.00 | $-17.31M | — | — | — |